Suchergebnisse - "Fackler, Oliver Till"

PubPharm (78)

1

Characterization of the HIV-1 integration site landscape and chromatin determinants of integration in microglia cellular models and CD4+ T cells

Erschienen: Dissertation, Ruprecht-Karls-University Heidelberg, 2024

von Rheinberger, M. | Fackler, O.

2

Genomic profiling of HIV-1 integration in microglia cells links viral integration to the topologically associated domains

enthalten in: Cell reports | 13 February 2023

von Rheinberger, M. | Costa, A. | Kampmann, M. | +13

3

A conserved acidic residue in the C-terminal flexible loop of HIV-1 nef contributes to the activity of SERINC5 and CD4 downregulation

enthalten in: Viruses | 28 February 2023

von Firrito, C. | Bertelli, C. | Rosa, A. | +8

4

Characterization of the HIV-1 integration site landscape and chromatin determinants of integration in microglia cellular models and CD4+ T cells

Erschienen: Dissertation, Ruprecht-Karls-University Heidelberg, 2024

von Rheinberger, M. | Fackler, O.

5

The impact of the population context on virus infection, IFN response, and homeostatic immune signaling in mucosal epithelial cells

Erschienen: Dissertation, Ruprecht-Karls-University Heidelberg, 2023

von Metz Zumarán, C. | Fackler, O.

6

Ex vivo and in vivo suppression of SARS-CoV-2 with combinatorial AAV/RNAi expression vectors

enthalten in: Molecular therapy : the journal of the American Society of Gene Therapy | 2022

von Becker, J. | Stanifer, M. | Leist, S. | +12

7

Ex vivo and in vivo suppression of SARS-CoV-2 with combinatorial AAV/RNAi expression vectors

enthalten in: Molecular therapy | 14 January 2022

von Becker, J. | Stanifer, M. | Leist, S. | +12

8

SARS-CoV-2 variants of concern display enhanced intrinsic pathogenic properties and expanded organ tropism in mouse models

enthalten in: Cell reports | 2022

von Stolp, B. | Stern, M. | Ambiel, I. | +10

9

SARS-CoV-2 variants of concern display enhanced intrinsic pathogenic properties and expanded organ tropism in mouse models

enthalten in: Cell reports | February 15, 2022

von Stolp-Rastätter, B. | Stern, M. | Ambiel, I. | +10

10

The FDA-approved drug cobicistat synergizes with remdesivir to inhibit SARS-CoV-2 replication in vitro and decreases viral titers and disease progression in Syrian hamsters

enthalten in: mBio | 1 March 2022

von Shytaj, I. | Fares, M. | Gallucci, L. | +26

1
2
3
4
5
6
7
8
Nächster »
[8]